MYC and neoplasm: Additionally, blocking CCL7 and CCR2 with the chemokine inhibitor Bindarit and the CCR2 antagonist INCB3344, respectively, effectively reversed the recruitment of M2‐like macrophages by MYC‐overexpressing tumor cells, suggesting that the recruitment was CCL7‐CCR2 dependent (Figure S7D, Supporting Information).